image
Healthcare - Biotechnology - NASDAQ - GB
$ 28.06
-8.39 %
$ 1.4 B
Market Cap
-27.51
P/E
CASH FLOW STATEMENT
26.1 M OPERATING CASH FLOW
786.43%
-355 M INVESTING CASH FLOW
-6446.16%
344 M FINANCING CASH FLOW
901.23%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Immunocore Holdings plc
image
40m40m20m20m00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)20192019202020202021202120222022202320232024202420252025
Net Income -51.1 M
Depreciation & Amortization 4.2 M
Capital Expenditures -5.17 M
Stock-Based Compensation 34.2 M
Change in Working Capital 45.1 M
Others 43.8 M
Free Cash Flow 20.9 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
OPERATING CASH FLOW
Net Income (51.1) (43.4) (41.2) (131.5) (74.1) (103.9) (71.6)
Depreciation & Amortization 4.2 4.1 6.1 7.0 9.0 9.2 6.7
Deferred Income Tax 0 0 (2.9) (9.4) (13.3) (22.3) (16.5)
Stock Based Compensation 34.2 32.5 32.9 48.9 8.2 3.1 0.7
Other Operating Activities (6.4) 4.0 (7.4) (14.9) 38.5 22.6 (3.4)
Change in Working Capital 45.1 5.8 (12.9) (16.8) (28.8) (10.1) 67.6
Cash From Operations 26.1 2.9 (31.3) (129.7) (60.6) (101.4) (16.6)
INVESTING CASH FLOW
Capital Expenditures (5.2) (5.4) (2.2) (1.0) (3.1) (4.3) (3.5)
Other Items (350.0) 0 2.4 0.5 3.5 0.1 61.6
Cash From Investing Activities (355.1) (5.4) 0.2 (0.5) 0.5 (4.1) 58.0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0
Total Debt Repaid 352.5 0 0 0 45.1 (4.0) 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities (8.6) 34.3 (1.3) (10.6) (0.1) (0.7) 0.1
Cash From Financing Activities 343.9 34.3 138.2 276.3 115.9 55.1 0.1
CHANGE IN CASH
Net Change In Cash 13.1 40.2 114.3 146.0 55.8 (50.4) 41.5
FREE CASH FLOW
Free Cash Flow 20.9 (2.5) (33.5) (130.8) (63.6) (105.7) (20.2)